Omeprazole Market Report 2026

Omeprazole Market Overview

• Omeprazole market size has reached to $2.5 billion in 2025 • Expected to grow to $3.46 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: Impact Of Rising Gastric Cancer Incidence On The Growth Of The Omeprazole Market • Market Trend: Advancements In Omeprazole Formulations • North America was the largest region in 2025.

What Is Covered Under Omeprazole Market?

Omeprazole is a proton pump inhibitor, used to treat acid reflux, stomach ulcers, and other conditions involving excessive stomach acid. It works by irreversibly blocking the H+/K+ ATPase enzyme system (the proton pump) of the gastric parietal cells, thereby reducing the production of stomach acid. The main dosage forms of omeprazole are capsule, powder, and tablets. Capsules are solid dosage forms in which the drug is enclosed within a soluble container or shell, usually made of gelatin. It is prescribed to treat a range of conditions, including duodenal ulcers, gastric ulcers, gastroesophageal reflux disease, erosive esophagitis, and others, and is distributed through various channels including hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Omeprazole Market Growth Forecast?

The omeprazole market size is expected to see strong growth in the next few years. It will grow to $3.46 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising demand for personalized gastric treatments, growth in online pharmacy channels, technological advancements in drug delivery systems, increasing adoption of omeprazole for pediatric and geriatric populations, expansion of pharmaceutical manufacturing in emerging markets. Major trends in the forecast period include rising adoption of digital health platforms for prescription management, integration of ai in drug formulation and personalized therapy, development of precision medicine approaches for gastrointestinal disorders, automation in pharmaceutical manufacturing and quality control, iot-enabled monitoring of drug storage and distribution.

Global Omeprazole Market Segmentation

1) By Dosage Form: Capsule, Powder, Tablet 2) By Indication: Duodenal Ulcer, Gastric Ulcer, Gastroesophageal Reflux Disease, Erosive Esophagitis, Other Indications 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Capsule: Delayed-Release Capsules, Immediate-Release Capsules 2) By Powder: Oral Suspension Powder, Injectable Powder 3) By Tablet: Delayed-Release Tablets, Immediate-Release Tablets

What Is The Driver Of The Omeprazole Market?

The increased incidence of gastric cancers is expected to propel the growth of the omeprazole market going forward. Gastric cancers refer to malignancies that originate in the lining of the stomach. The increased incidence of gastric cancers is due to chronic Helicobacter pylori infection, heavy alcohol consumption, genetic predisposition, chronic gastritis, obesity, and geographical variations in prevalence. Omeprazole, a proton pump inhibitor, helps manage gastric cancers by reducing stomach acid production, which can alleviate symptoms, improve quality of life, and support healing of ulcers or lesions in the stomach lining. For instance, in January 2025, according to the American Cancer Society (ACS), a US-based health organization, about 30,300 new cases of gastric cancer were reported, with 17,720 cases in men compared to 12,580 cases in women, indicating that men are affected more frequently than women. Similarly, of the approximately 10,780 deaths from this cancer, 6,400 were men, and 4,380 were women, showing a higher mortality burden among men. Therefore, the increased incidence of gastric cancers is driving the omeprazole industry.

Key Players In The Global Omeprazole Market

Major companies operating in the omeprazole market are Pfizer Inc., AstraZeneca plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Macleods Pharmaceuticals Pvt Ltd., Perrigo Company plc, Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla, Apotex Inc., Amneal Pharmaceuticals, Lupin Limited, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals, Jubilant Generics Limited, Accord Healthcare, Hetero Healthcare Limited, Zydus Cadila, Ranbaxy Laboratories Limited

Global Omeprazole Market Trends and Insights

Major companies operating in the omeprazole market are developing ready-to-use liquid formulations to enhance patient convenience and compliance, particularly for those who have difficulty swallowing tablets or capsules. Ready-to-use liquid formulations of omeprazole help to improve patient compliance, enhance convenience, provide accurate dosing, offer a faster onset of action, and ensure enhanced medication stability. For instance, in February 2024, Alkaloid AD, a North Macedonia-based pharmaceutical manufacturing company, launched liquid Omeprazole. It is the first ready-to-use liquid Omeprazole for reflux esophagitis and GERD patients unable to swallow tablets, and it features a dual-chamber package. This innovation provides a more practical and accessible treatment option for patients who have difficulty in swallowing tablets or capsules, such as young children, adult patients with dysphagia, and those with gastric feeding tubes or geriatric patients. The company has obtained the first international patent for a value-added medicine (VAM) for this product and has received marketing authorizations for the Macedonian and UK markets.

What Are Latest Mergers And Acquisitions In The Omeprazole Market?

In February 2025, Epicur Pharma, a US-based veterinary pharmaceutical outsourcing facility, collaborated with Bova Group to introduce a patented injectable omeprazole suspension for horses in the United States. Through this partnership, Epicur aims to broaden its equine health portfolio by bringing Bova’s proven injectable omeprazole formulation to treat equine gastric ulcers across the U.S. market. Bova Group is a UK-based manufacturer of the formulation of omeprazole injection as a veterinary medicine.

Regional Outlook

North America was the largest region in the omeprazole market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Omeprazole Market?

The omeprazole market consists of sales of delayed-release capsules, oral disintegrating tablets, and oral suspensions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Omeprazole Market Report 2026?

The omeprazole market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the omeprazole industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.